Anesthetic preconditioning (APC) and ischemic preconditioning (IPC) are lost with normal aging. Here, we investigated age-related difference between phosphoglycogen synthase kinase-3beta (pGSK-3β) and pGSK-3β with modulators of mitochondrial permeability transition pore, including adenine nucleotide translocase (ANT), cyclophilin-D, or voltagedependent anion channel. APC or IPC significantly increased pGSK-3β in the young groups in both the cytosol and the mitochondria and also significantly increased pGSK-3β in co-immunoprecipitates with ANT. Importantly, the level of cyclophilin-D in co-immunoprecipitates with ANT was significantly decreased in the young APC and IPC groups, but not in old rats. We also found that APC or IPC significantly prolonged mitochondrial permeability transition pore opening time in the young cardiomyocytes under oxidative stress, but not in the elderly. Attenuation of APC or IPC protection in the aging heart is associated with failure to reduce ANT-cyclophilin-D interactions and to decreased pGSK-3β responsiveness of ANT, critical modulators of mitochondrial permeability transition pore.
T HERE is increasing evidence that the mitochondrial permeability transition pore (mPTP), which plays a central role in mitochondria-mediated death pathways (1, 2) , is opened in the myocardium as a result of ischemia/ reperfusion (I/R) injury and represents the key step leading to necrosis and programmed cell death (3, 4) . Although the molecular composition is still only partially known or agreed upon, the current view of the mPTP is that it includes adenine nucleotide translocator (ANT), voltagedependent anion channel (VDAC), and cyclophilin D (CyP-D), which form a modulated pore, whose opening is triggered by binding of CyP-D to ANT (5) . One of the protein kinases that regulate mPTP opening is glycogen synthase kinase 3β (GSK-3β), a constitutively active Ser/ Thr protein kinase, the activity of which is regulated by phosphorylation, intracellular translocation, and complex formation with other proteins (6, 7) . It has been demonstrated that GSK-3β inhibition limits myocardial infarction size at the time of myocardial reperfusion following pharmacologic and ischemic preconditioning (IPC) (8, 9) . We and others have shown that the effectiveness of anesthetic preconditioning (APC) and IPC decreases with advancing age, yet the mechanism whereby age attenuates the protective effects in vivo has not been elucidated (10) (11) (12) (13) (14) . Moreover, studies of mPTP opening and the effects of age on pore components are lacking. We hypothesize that aging induces damage to mPTP protein modulators/components of the mPTP altering their interactions and that this accounts for the loss of APC and IPC. We characterized changes in protein regulators of mPTP and their interactions with phosphoglycogen synthase kinase 3β (pGSK-3β)/GSK-3β during APC or IPC in the aged myocardium. We also determined mPTP opening under oxidative stress in the aged cardiomyocytes and the effectiveness of isoflurane or hypoxia/reoxygenation (H/R) treatment to influence the time to opening.
Materials and Methods
All experimental procedures and protocols used in this investigation were reviewed and approved by the Animal Care and Use Committee of SUNY Stony Brook. Furthermore, all procedures conformed to the Guiding Principles in the Care and Use of Animals of the American Physiologic Society and were in accordance with the Guide for the Care and Use of Laboratory Animals.
General Preparation and Surgery Protocol
The general preparation and surgery protocol have been previously described (14) . In brief, male Fischer 344 rats of the following age groups were obtained: 3-5 months (240-300 g) and 20-24 months (420-490 g; National Institute on Aging, Bethesda, MD).
The experimental design is illustrated in Figure 1 . Protocol A, n = 7 each group, was designed for co-immunoprecipitation studies following in vivo treatments. In six separate experimental groups, rats of similar age, young (Y) and old (O), were randomly assigned to three groups: sham control (SC), early phase isoflurane (ISO), and IPC. In the ISO group, rats were administrated 1.0 MAC ISO for 30 minutes followed by 45 minutes of washout. In the IPC group, rat hearts were subjected to 5 minutes of ischemia and 5 minutes of reperfusion for a total of three cycles as previously described (13) . At the end of the experiment, each animal was euthanized with an overdose of sodium thiobutabarbital. The left ventricular samples were then collected. Protocol B, n = 5 each group, was designed for oxidative stress studies in isolated cardiomyocytes. Within each age group, cardiomyocytes were divided into control, ISO, or H/R treatment groups and were loaded with tetramethylrhodamine ethyl ester (TMRE) fluorescent dye for 25 minutes and then incubated with or without isoflurane (0.5 mM) for 30 minutes. The appropriate volume of isoflurane stock solution dissolved in dimethylsulfoxide was added to Tyrode buffer to obtain the 0.5 mM (15) . Isoflurane concentration was verified by gas chromatography before and after experiment, and varied ±10% of reported 0.5 mM. H/R preconditioning was achieved by incubating myocytes for 10 minutes in ischemic buffer containing 123 mM NaCl, 8 mM KCl, 5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 1.0 mM MgCl2, 20 mM sodium lactate with 1.0 mM CaCl 2 , pH 6.8 equilibrated with 90% N2-10% CO2. And followed by incubation in a normal Tyrod buffer containing 140 mM NaCl, 5.4 mM KCl, 5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid. 1.0 mM MgCl2, 10 mM glucose with 1.0 mM CaCl 2 (pH 7.4) for 20 minutes of simulated reperfusion (16, 17) . After 15 minutes of washout/memory, each experimental group underwent laserillumination-induced oxidative stress, and mPTP openings were measured by monitoring TMRE fluorescence by laserscanning confocal microscopy.
extraction of Mitochondrial and cytosolic Proteins
Fresh tissue samples were homogenized using a polytron homogenizer in ice-cold sucrose buffer containing 300 mM sucrose, 5 mM 2-[(2-Hydroxy-1,1-bis(hydroxymethyl) ethyl)amino]ethanesulfonic acid, 0.2 mM ethylene glycol tetraacetic acid (pH 7.2 with KOH). The homogenate was centrifuged at 800g for 10 minutes, and then the supernatant was centrifuged at 10,000g for 15 minutes. The 10,000g mitochondrial pellet was washed twice with sucrose buffer and resuspended in lysis buffer (20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM NaVO 3 , 1 mM NaF, 2.5 mM Na 4 P 2 O 7 , 1% NP40, 0.1% sodium dodecyl sulfate, 1 mM dithiothreitol, 1 mM phenylmethanesulfonyl fluoride, and a complete proteinase inhibitor cocktail (one tablet per 10 mL). The postmitochondrial supernatant was then centrifuged at 100,000g for 60 minutes to obtain the cytosolic fraction (supernatant) and postmitochondrial membrane fraction (pellet). At this time, the antiphosphatase and antiproteinase reagents were added to the same concentrations to the cytosolic and postmitochondrial membrane fractions. Protein concentrations in each fraction were determined using the Bio-Rad Protein Assay Kit. Fractionated samples were stored at −80°C until immunoblotting and/or co-immunoprecipitation. Mitochondrial and cytosol protein markers were confirmed by immunoblotting using antiprohibitin (PHB) antibody for mitochondria enrichment, anticytochrome c antibody to demonstrate intact mitochondria and anti-Glyceraldehyde-3-phosphate dehydrogenase antibody for cytoplasm ( Figure 2 ).
Western Blot analyses of pGSK-3β in the cytosol and Mitochondria compartments in the Rat Heart
Equivalent amounts (30 µg each) of protein from cytosol and mitochondria were mixed with 2× Laemmeli buffer and heated at 95°C for 5 minutes before electrophoretic separation described below. All samples were separated on a 12% polyacrylamide gel and transferred to a polyvinylidine fluoride membrane. After blocking with 5% nonfat dry milk in Tris-buffered saline with 0.1 % Tween-20 (containing 0.1% Tween-20), polyvinylidine fluoride membranes were incubated with rabbit polyclonal antipGSK-3β (Ser9; dilution 1:1,000) at 4°C overnight. The primary antibody binding was detected with a secondary antimouse or rabbit antibody (1:10,000) and visualized with enhanced chemiluminescence. To determine total GSK-3β, the membrane was stripped with restore stripping buffer (100 mM β-mercaptoethanol, 2% sodium dodecyl sulfate, 62.5 mM Tris-HCl, pH 6.8) and reprobed with GSK-3β antibody (1:1,000). Quantitative analysis of the band densities from X-ray film was performed using NIH ImageJ 1.45). Band densities obtained from pGSK-3β were normalized against the concentrations of total GSK-3β in the same samples. pGSK-3β/GSK-3β was expressed as ratio immunoblot intensities ×100. Glyceraldehyde-3-phosphate dehydrogenase and antiprohibitin were used as internal control for cytoplasm and mitochondria, respectively.
co-immunoprecipitation and immunoblotting
Equal amounts of protein were analyzed by immunoblot assays with the use of antibodies against GSK-3β, pGSK-3β, ANT, VDAC, and CyP-D. In brief, 500 µg of mitochondrial fractions were solubilized by 500 µL of lysis buffer and pre-incubated with 30 µL of protein-G magnetic beads suspension for 30 minutes to remove proteins that can bind nonspecifically to the beads. The supernatant was incubated with antibodies against GSK-3β, pGSK-3β, ANT, VDAC, or CyP-D overnight, and then for 4 hours with fresh magnetic beads that were then trapped by the applied magnetic field, and the supernatant fluid removed. The beads were washed three times using lysis buffer, resuspended in 30 µl of 2× sodium dodecyl sulfate sample loading buffer (Bio-Rad), and immunoprecipitated proteins were then eluted by boiling in sodium dodecyl sulfate sample buffer and separated on a 12% polyacrylamide gel by electrophoresis. IgG bands were visualized as an internal control for consistency of sample recovery and gel loading.
isolation of cardiomyocytes
Ventricular myocytes were obtained by enzymatic dissociation as previously described (11) . Briefly, the aorta of each animal was cannulated and heart was perfused ex vivo for 15-20 minutes with a perfusion buffer containing 140 mM NaCl, 5.4 mM KCl, 5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 1.0 mM MgCl 2 , 10 mM glucose with 50 µM CaCl 2 (pH 7.40 gassed with 95% O 2 5% CO 2 , at 37°C). The proteases dispase II (0.1 mg/mL, Roche), collagenase type 2 (331 U/mg, Worthington), 1.0 and 1.2 mg/mL, respectively, for both young and old rat hearts, were added. After perfusion, the left ventricles were minced and the cell suspension was decanted and filtered through a 225 µm polyethylene mesh to remove large fragments. The isolated cardiomyocytes were finally suspended in Tyrode buffer. Only quiescent, rod-shaped myocytes with visible striations and no visible membrane damage were used in our experiments. As in previous work, a decrease in myocyte yield with age was observed (18) . Following isolation, ventricular myocytes were then plated in Tyrode buffer onto laminin-precoated glass-bottomed petri dishes. Myocytes were allowed to recover for 1 hour and were used for experiments within 4 hour.
opening of mPTP in cardiomyocytes
Freshly isolated cardiomyocytes were loaded with the fluorescent probe TMRE (100 nM). Cardiomyocytes were then placed in a laminin-coated glass-bottomed petri dish on the stage of the laser-scanning confocal microscope (Fluoview FV1000, Olympus) and viewed with 60 × 1.4 NA oil-immersion objective lens. The experimental protocol is shown in Figure 1 Protocol B. TMRE generates Reactive oxygen species (ROS) within mitochondria during laser illumination, which leads to opening of mPTP as described previously (11) . In brief, regions of the myocyte (30 × 30 µm 2 ) were subjected to laser-induced localized production of ROS. Increasing ROS induces mPTP opening, which collapses mitochondrial membrane potential (Δψ m ) that can be visualized with the same dye. Images were analyzed using NIH Image J 1.45. Background was calculated by subtraction of a cell-free area. After background subtraction, images were corrected for photo bleaching by normalization to a predetermined monoexponential decay. This decay was calculated from the differences of intensities averaged over the whole recording in the absence of mPTP opening. The peak-corrected signal was normalized to 100%, and the nadir to 0%. Time required for a 50% decrease in TMRE fluorescence emission signal is defined as the time to mPTP opening (t mPTP ) (19) . ROS scavenger Trolox (2 mM) and mPTP inhibitor cyclosporin A (CsA, 0.5 µM) were used as a control of the changes in TMRE that were due to ROS generation and mPTP opening, respectively ( Figure 6A ). Cardiomyocytes were isolated from at least five individual animals from each age group, and the results of at least five cells from each animal in each treatment group were analyzed.
Statistical analysis
Results were given as mean ± SD. Two-way analysis of variance with Tukey's post-test was performed on baseline hemodynamics, immunoblotting blotting data and cardiomyocyte TMRE data. For in vivo treatments, at least seven animals were used per group. Differences of p < .05 were considered significant. Analyses were performed on SigmaStat.
Results
Seventy-two animals were instrumented in the experiments. The ages and body weights were similar within each age group.
Systemic Hemodynamics
No differences in the baseline hemodynamics were observed among experimental groups and no differences were observed in mean arterial blood pressure between the young isoflurane (YISO) and old isoflurane (OISO), young IPC (YIPC), and old ischemic predonditioning (OIPC) groups. APC and IPC, however, significantly (p < .05) decreased the Figure 3 . Phosphorylation status of p-GSK-3β/GSK-3β in the cytoplasm and mitochondrial fractions, prepared from ventricles of hearts untreated or subjected to APC or IPC in vivo. Representative blots (lower panels) and summaries of group data (upper panels). Cyto = cytosolic, GAPDH = glyceraldehyde 3-phosphate dehydrogenase, IPC = ischemic preconditioning, ISO = isoflurane, SC = sham control, Mito = mitochondria, PHB = prohibitin, mitochondrial marker. * p < .05 ISO or IPC versus SC in the same age groups. # p < .05 old rats versus young rats in the same treatment groups. Values are mean ± SD, n = 7 per group. Data were mean ± SD. C = control, HR = heart rate, IPC = ischemic preconditioning, ISO = isoflurane, MAP = mean arterial blood pressure, O = old, Y = young. *p < .05 significantly different from baseline within the same group. n = 7 per group. mean arterial blood pressure and heart rate (p < .05) in the preconditioned groups when compared with their respective control groups, as observed previously (14) . There were no differences in mean arterial blood pressure and heart rate during the memory period in the preconditioned groups when compared with their respective control groups ( Table 1) .
effects of aPc or iPc on anT, VDac, and cyP-D in the young and old rat hearts
In our experiments, no significant changes in the levels of ANT and VDAC were observed in either the control, following APC, or following IPC in the young and old rat hearts or in comparing the young and old myocardial tissues. There were significant increases in CyP-D levels in the aged rat hearts compared with the young (YSC = 100.0 ± 27.7%, OSC = 159.6 ± 19.5%, p < .05). However, these CyP-D levels were not affected by 30 minutes of isoflurane or IPC treatment in either young or old rat heart (Figure 2 ).
pGSK-3β in the young and old rat hearts during aPc or iPc
The densities of pGSK-3β were normalized against GSK-3β expression. In the YISO or YIPC group compared with YSC group, isoflurane or IPC increased the ratio of pGSK-3β/GSK-3β in both cytosol and mitochondrial fractions (YSC cyto = 24.6 ± 9.4%, YISO cyto = 49.5 ± 15.6%, YIPC cyto = 53.6 ± 16.8%, p < .05; YSC mito = 20.7 ± 8.69%, YISO mito = 81.7 ± 11.8%, YIPC mito = 90.5 ± 8.5%, p < .05). Interestingly, OSC was associated with significantly increased levels of pGSK-3β/GSK-3β compared with the YSC (YSC mito = 20.7 ± 8.6%, OSC mito = 78.5 ± 9.7%, p < .05) in the mitochondria but not in the cytoplasm. However, pGSK-3β levels and the ratios of pGSK-3β/GSK-3β were unchanged by either 30 minutes isoflurane or 30 minutes ischemic/reperfusion treatment in both cytosol and mitochondrial compartments in the old rat heart (Figure 3) .
GSK-3β interactions With Modulators/components of mPTP in the Young and old Rat Hearts During aPc or iPc
As shown in Figure 4A , APC or IPC increased the amount of both pGSK-3β and GSK-3β that immunoprecipitated with ANT from the mitochondrial extracts of YISO or YIPC rats compared with the extracts from the YSC group (immunoprecipitation [IP] with pGSK-3β, immunoblotting [IB] with ANT: YSC = 100.0 ± 27.6%, YISO = 172.0 ± 40.3%; YIPC = 183.1 ± 34.6%; IP with GSK-3β, IB with ANT: YSC = 100.0 ± 35.3%, YISO = 162.7 ± 3 1.6%, YIPC = 181.4 ± 25.7%; p < .05). All data were normalized to YSC. pGSK-3β and GSK-3β that immunoprecipitated with ANT were significantly elevated in the OSC group compared with YSC (IP with pGSK-3β, IB with ANT: OSC = 174.6 ± 32.6%; IP with GSK-3β, IB with ANT: OSC = 197.3 ± 40.3%, p < .05), but there were no significant differences observed between the old OISO, OIPC and OSC groups. We could not detect any pGSK-3β/ VDAC ( Figure 4B ), GSK-3β/CyP-D, or pGSK-3β/CyP-D ( Figure 4C ) complexes in mitochondrial samples from either young or old animals.
anT interactions With cyP-D in the Young and old Rat Heart after aPc or iPc
As shown in Figure 5 , the levels of ANT that co-immunoprecipitate with CyP-D were significantly decreased by isoflurane or IPC treatment (IP with CyP-D, IB with ANT: YSC = 100.0 ± 27.6%, YISO = 51.3 ± 18.3%, YIPC = 48.6 ± 19.3%; IP with ANT, IB with CyP-D: YSC = 100.0 ± 23.8%, YISO = 47.3 ± 17.5%, YIPC = 38.6 ± 15.6%, p < .05). In contrast, this interaction was not significantly affected by preconditioning in aged animals. Figure 6C shows a typical recording of TMRE fluorescence obtained from a 30 × 30 µm 2 region, in isolated cardiomyocytes, as assessed by confocal microscopy. ROS were rapidly produced from laser excitation of TMRE and TMRE fluorescence at 590 nm was recorded as described. AOC or H/R prolonged the t mPTP in the young cardiomyocytes in the setting of oxidative stress, which suggested an increase in the ROS threshold required to induce mPTP opening (YC = 290.7 ± 52.4, YISO = 364.2 ± 38.3, YH/R = 355.6 ± 41.3, p < .05, unit = second). In contrast, cardiomyocytes from old ventricles were insensitive to preconditioning in that no differences in t mPTP were observed (OC = 174.0 ± 58.5, OISO = 171.7 ± 62.6, OH/R = 186.7 ± 39.4, p > .05, unit = second). The data are summarized in Figure 6B . 
Measurements of mPTP opening in Vitro

Discussion
The multiple cardioprotective signaling pathways that are activated by preconditioning converge on mitochondria (20, 21) . There are distinct subcellular pools of Akt, protein kinase C, extracellular-regulated kinases, and GSK-3β that are localized in mitochondria in addition to the cytosol. Some proteins such as GSK-3β appear to be at the end of the signaling pathways and directly responsible for inhibiting mPTP opening (21) . In our previous studies, we had shown that isoflurane-induced cardiac protection, which was associated with increased GSK-3β levels in the young but not in the old rat myocardium (12) . The study presented here is, to our knowledge, the first to examine age-related interactions of pGSK-3β or GSK-3β with modulators/ components of mPTP in the rat heart following APC or IPC. Several pertinent findings are reported in this study. First, we extended our previous findings and demonstrated that APC or IPC increased the levels of pGSK-3β in both cytosol and mitochondrial fractions from the myocardium of young animals. pGSK-3β levels, however, were only highly elevated in the mitochondrial fraction from senescent animals and were unaffected by APC or IPC. Second, APC or IPC significantly increased the formation of pGSK-3β/ ANT complex in the young rats, whereas comparable levels of pGSK-3β were already associated with ANT in the old sham controls, and this was not increased further in old animals by APC or IPC. Third, our most important observation is that the amount of ANT associated with CyP-D was substantially reduced by APC or IPC in young but not old animals.
The major determinant of cardiomyocyte death following an episode of I/R injury is mitochondrial dysfunction arising from the formation of mPTP, whose irreversible opening at the onset of myocardial reperfusion is a critical mediator of lethal myocardial reperfusion injury (20, 22, 23) . It is well known that the aging myocardium is subjected to enhanced oxidative stress, which damages mitochondria (24) . Indeed, we have previously reported high levels of ROS in the myocardium from aged rats (14) . Oxidative damage to mitochondria in concert with mitochondrial calcium overload favors the onset of mPTP opening and subsequent release of cytochrome C (25) .
Although the mechanism whereby GSK-3β phosphorylation modulates mPTP structure and function remains unclear, it appears that suppression of ANT/CyP-D interactions by binding of pGSK-3β to ANT and reduction in GSK-3β-mediated phosphorylation of p53 contribute to elevation of the threshold for mPTP opening (5) . Other studies have shown that inhibitors of GSK-3β slow ATP consumption under these conditions, which could be attributable to inhibition of ATP entry into the mitochondria through the VDAC and/or ANT or to inhibition of the F1F0-ATPase, that are associated with reduced VDAC phosphorylation (26) .
In our study, complex formation between pGSK-3β and ANT induced by APC or IPC in the young heart was associated with inhibition of CyP-D binding to ANT. CyP-D binding to ANT is known to sensitize mPTP for opening (27) (28) (29) . Studies have shown that interactions of ANT with CyP-D result in mPTP opening in response to Ca 2+ overload and subsequent necrosis (30) . Furthermore, deletion of CyP-D gene has been shown to afford significant resistance against Ca 2+ overload, oxidant stress, and I/R injury (31) (32) (33) (34) . It is possible that direct interaction of pGSK-3β with ANT results in reduction of ANT affinity for CyP-D, leading to an increase in the threshold for mPTP opening, but this does not appear to be modulated in senescent myocardium. Indeed, we could demonstrate an increased threshold for ROS-induced opening of mPTP, following isoflurane exposure or H/R treatment in young, but not old cardiomyocytes.
In contrast with its effect on pGSK-3β-ANT interaction, APC or IPC did not induce formation of pGSK-3β/ VDAC and pGSK-3β/CyP-D complex. Thus, a VDAC/ CyP-D complex may not be a crucial target of pGSK-3β in myocardial protection affected by APC or IPC, which is consistent with the findings that ablation of VDAC genes did not alter mPTP responsiveness to Ca 2+ overload in isolated mitochondria, suggesting that VDAC is dispensable for mPTP opening, at least under some conditions, and is not required for mPTP-mediated cell death (34) .
In contrast to the young animals, APC or IPC failed to reduce binding of CyP-D to ANT in the old animals. The levels of this complex in OSC, OAPC, and OIPC groups were similar to the YSC. Taken together with the pGSK-3β results, we can suggest a molecular model to explain the loss of APC or IPC in senescent animals. Chronically high levels of ROS caused by aging induce damage to lipid, as well as protein constituents of the mitochondria including CyP-D and ANT. This damage prevents the appropriate modulation of CyP-D/ANT complex by pGSK-3β to raise the pore to a high ROS threshold state. Despite the already substantial levels of pGSK-3β bound to ANT in the old myocardium, allosteric changes in the CyP-D/ANT complex fail to occur or can no longer be effectively transmitted to other pore components, thereby leaving mPTP insensitive to isoflurane and trapped in the lower ROS threshold state.
Possible limitations of our study. (a) Intact animals or isolated cardiomyocytes were only exposed to APC or IPC without subjecting to I/R injury. However, we and others have previously shown that these protocols result in early phase preconditioning with resulting cardioprotection. (b) In this study, we examined interactions of pGSK-3β with three major subunits of mPTP, ANT, VDAC, and CyP-D, but the involvement of other proteins in pGSK-3β mediated regulation of mPTP cannot be excluded. (c) Whether binding of pGSK-3β to ANT is indirect and through other proteins, possibly a distinct GSK-3β substrate, and/or membrane proteins other than ANT will need to be investigated further. (d) A single dose of isoflurane was used in both age groups, although the sensitivity to anesthetics differs with age. Nonetheless, the anesthetic concentration we used was within previous ranges studied for APC. (e) It should be pointed out that our in vitro model only simulates ROS production during the reperfusion of ischemic myocardium and may not include other contributors to mPTP opening in cardiomyocytes during reperfusion, particularly the increased influx of Ca 2+
. (e) We did not directly test the role of the individual mPTP modulators/components or their complexes in governing the threshold of mPTP opening by I/R injury or their role in the failure of APC or IPC in the senescent myocardium.
In conclusion, our results raise the possibility that the lack of isoflurane-induced cardioprotection in the older animals can be explained by age-related differences in the Akt/GSK-3β prosurvival signaling pathway and subsequent insensitivity of mPTP to inhibitory modulation by this volatile anesthetic. Reduction in affinity of ANT for CyP-D by increased pGSK-3β binding to ANT may be necessary for raising the threshold for mPTP opening in response to ROS and suppressing cell death following I/R injury. We suggest that attenuation of APC in the aging rat heart is associated with failure to reduce ANT/CyP-D interactions or decreased pGSK-3β responsiveness of ANT, a key modulator/component of the pore. Whether this mechanism actually causes attenuation of APC-induced mPTP closure in the aged rat heart, however, remains the subject of further study.
